The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Incidence of acute kidney injury in patients with relapsed and refractory multiple myeloma treated with teclistamab vs chimeric antigen receptor T-cell therapy.
 
Mariam Charkviani
No Relationships to Disclose
 
Lisa E Vaughan
No Relationships to Disclose
 
Tyler B Sandahl
Employment - Mayo Clinic; UnitedHealthcare (I)
Stock and Other Ownership Interests - crispr therapeutics; Sio Gene Therapies; United Health Group (I)
Consulting or Advisory Role - Janssen
Research Funding - nference
Travel, Accommodations, Expenses - Janssen
 
Yi Lin
Consulting or Advisory Role - Adicet Bio (Inst); Bristol-Myers Squibb (Inst); Caribou Biosciences (Inst); Chimeric Therapeutics (Inst); Fosun Kite (Inst); Genentech (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Nektar (Inst); NexImmune (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Vineti (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Janssen Oncology (Inst)
 
Nelson Leung
Stock and Other Ownership Interests - Abbvie; senseonics; Verrica Pharmaceuticals
Research Funding - Omeros
 
Sandra M Herrmann
No Relationships to Disclose